The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea, according to a European clinical study in which the University of ...
“The reason sleep apnea can be bad is that any decrease in the quality of sleep can affect you day to day or over the course of your life,” said Dr Brian Chen, a sleep doctor at the Cleveland Clinic. ...
Abstract: Obstructive sleep apnea (OSA) remains significantly underdiagnosed due to limitations associated with traditional polysomnography (PSG), including complexity, high cost, and patient ...
Plaintiffs are going to court to challenge CVS Caremark’s decision to stop covering Zepbound, a weight-loss drug that is also used to treat sleep apnea. Plaintiff Martin Hamburger filed his lawsuit in ...
People found to have “poor sleep” in a new test are more likely than others to have brains showing signs of faster ageing, a new study reveals. Several studies have so far found a link between poor ...
At World Sleep 2025, a discussion group examined the emerging role of GLP-1 receptor agonists in obstructive sleep apnea (OSA), particularly tirzepatide (Zepbound), which late last year became the ...
People living in areas of elevated air pollution may be at risk of more serious sleep apnea events, according to a large new study that spans multiple countries. However, being aware of your air ...
Abstract: The extant automatic diagnostic technologies for sleep apnea primarily focus on the accuracy of apneahypopnea index (AHI) estimation and severity classification, ignoring the accurate ...
The link between OSA and headaches is well established. “Morning headaches have long been recognized as a marker for sleep apnea,” says Avram Gold, MD, director of the sleep medicine fellowship at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback